Literature DB >> 7462225

Aggregation and crystallization of hemoglobins A, S, and C. Probable formation of different nuclei for gelation and crystallization.

K Adachi, T Asakura.   

Abstract

The oxy and carbonmonoxy forms of Hb A and Hb S formed aggregates or gels when dissolved in phosphate buffers at concentrations above their solubility and warmed rapidly to 30 degrees C from 0 degrees C. Kinetic studies showed that although deoxy-Hb A and deoxy-Hb S aggregated with a clear exhibition of a delay time, the oxy and carbonmonoxy forms of Hb A and Hb S did not show a delay time. These results suggest that the deoxy forms of Hb A and Hb S aggregate according to the nucleation-controlled mechanism, while oxy- and carbonmonoxyhemoglobins aggregate by the simple linear aggregation mechanism. It was also found that the gels or aggregates of deoxy-Hb A and carbonmonoxy-Hb S could be converted to crystals by further incubation. The rate of crystallization depended upon the concentration of hemoglobin in the supernatant, with faster crystallization at higher concentrations. Similar experiments with deoxy-Hb C (beta 6 Glu leads to Lys) showed that this hemoglobin also crystallized after aggregation, with both reactions accompanied by a delay time. The activation energy for the crystallization reaction of deoxy-Hb C (100 approximately 150 kcal/mol) was much higher than that for the aggregation reaction (20 kcal/mol). These results suggest that deoxy-Hb A, deoxy-Hb S, and deoxy-Hb C form two types of nuclei that are specific to the formation of gels (or aggregates) or crystals. The concentration of hemoglobin measured after completion of crystallization was much lower than that measured after gelation (or aggregation) and was independent of the initial hemoglobin concentration. This concentration is assumed to be the real solubility of hemoglobin.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7462225

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Intermolecular interactions, nucleation, and thermodynamics of crystallization of hemoglobin C.

Authors:  Peter G Vekilov; Angela R Feeling-Taylor; Dimiter N Petsev; Oleg Galkin; Ronald L Nagel; Rhoda Elison Hirsch
Journal:  Biophys J       Date:  2002-08       Impact factor: 4.033

2.  Protein thermal aggregation involves distinct regions: sequential events in the heat-induced unfolding and aggregation of hemoglobin.

Authors:  Yong-Bin Yan; Qi Wang; Hua-Wei He; Hai-Meng Zhou
Journal:  Biophys J       Date:  2004-03       Impact factor: 4.033

3.  Aggregation of normal and sickle hemoglobin in high concentration phosphate buffer.

Authors:  Kejing Chen; Samir K Ballas; Roy R Hantgan; Daniel B Kim-Shapiro
Journal:  Biophys J       Date:  2004-10-01       Impact factor: 4.033

4.  Metastable mesoscopic clusters in solutions of sickle-cell hemoglobin.

Authors:  Weichun Pan; Oleg Galkin; Luis Filobelo; Ronald L Nagel; Peter G Vekilov
Journal:  Biophys J       Date:  2006-10-13       Impact factor: 4.033

5.  Two-step mechanism of homogeneous nucleation of sickle cell hemoglobin polymers.

Authors:  Oleg Galkin; Weichun Pan; Luis Filobelo; Rhoda Elison Hirsch; Ronald L Nagel; Peter G Vekilov
Journal:  Biophys J       Date:  2007-04-20       Impact factor: 4.033

6.  Sickle hemoglobin polymer melting in high concentration phosphate buffer.

Authors:  J G Louderback; S K Ballas; D B Kim-Shapiro
Journal:  Biophys J       Date:  1999-04       Impact factor: 4.033

7.  Relationship between beta4 hydrogen bond and beta6 hydrophobic interactions during aggregate, fiber or crystal formation in oversaturated solutions of hemoglobin A and S.

Authors:  Kazuhiko Adachi; Min Ding; Toshio Asakura; Saul Surrey
Journal:  Arch Biochem Biophys       Date:  2008-11-13       Impact factor: 4.013

8.  Pathway and mechanism of pH dependent human hemoglobin tetramer-dimer-monomer dissociations.

Authors:  Yao-Xiong Huang; Zheng-Jie Wu; Bao-Tian Huang; Man Luo
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

Review 9.  Rational Drug Design of Peptide-Based Therapies for Sickle Cell Disease.

Authors:  Olujide O Olubiyi; Maryam O Olagunju; Birgit Strodel
Journal:  Molecules       Date:  2019-12-12       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.